"Metastatic breast cancer" trang 1 - tải miễn phí từ tailieunhanh
Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer
10    77    0
Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer

Multicenter phase II study of Apatinib in non-triple-negative metastatic breast cancer
8    56    1
Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States

Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States
12    1    1
Metronomic chemotherapy with oral navelbine produces clinical benefit and low toxicity in metastatic breast cancer in K-Hospital

Metronomic chemotherapy with oral navelbine produces clinical benefit and low toxicity in metastatic breast cancer in K-Hospital
6    53    1
Metastatic breast cancer patient perceptions of somatic tumor genomic testing

Metastatic breast cancer patient perceptions of somatic tumor genomic testing
11    102    0
A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease

A retrospective study investigating the rate of HER2 discordance between primary breast carcinoma and locoregional or metastatic disease
7    58    1
Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer

Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer
10    99    0
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: A study protocol

A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: A study protocol
5    82    1
Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer

Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancer
10    72    0
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study
7    77    1
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
9    72    1
Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: An open-label, multi-center, non-comparative phase II study

Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast cancer: An open-label, multi-center, non-comparative phase II study
8    39    1
Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer

Whole-body total lesion glycolysis measured on fluorodeoxyglucose positron emission tomography/computed tomography as a prognostic variable in metastatic breast cancer
7    46    1
Real-world effectiveness of posttrastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: A retrospective observational study (KBCSGTR 1917)

Real-world effectiveness of posttrastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: A retrospective observational study (KBCSGTR 1917)
12    61    1
Circulating microRNAs miR-331 and miR195 differentiate local luminal a from metastatic breast cancer

Circulating microRNAs miR-331 and miR195 differentiate local luminal a from metastatic breast cancer
10    80    0
Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: Exploratory study using primary and paired metastatic lesions
14    77    1
Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer

Systemic high-dose intravenous methotrexate in patients with central nervous system metastatic breast cancer
6    73    0
Successfully treatment by eribulin in visceral crisis: A case of lymphangitic carcinomatosis from metastatic breast cancer

Successfully treatment by eribulin in visceral crisis: A case of lymphangitic carcinomatosis from metastatic breast cancer
5    46    0
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
8    56    1
Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
7    52    1